Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Bladder cancer cell line RNA-Seq data

PROVIDER: PRJNA805282 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18477716_1.fastq.gz	Fastqsanger.gz
	SRR18477716_2.fastq.gz	Fastqsanger.gz
	SRR18477717_1.fastq.gz	Fastqsanger.gz
	SRR18477717_2.fastq.gz	Fastqsanger.gz
	SRR18477718_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

H3K27me3 in human bladder transitional cell carcinoma cell line CL1207

Project description:The H3K27me3 ChIP-seq data for the human bladder transitional cell carcinoma cell line CL1207 were generated in order to detect regions of regional epigenetic silencing in this cell line and test the performance of several peak calling tools: CCAT (Xu et al., 2010) and HMCan (Ashoor et al., "HMCan M-bM-^@M-^S a tool to detect chromatin modifications in cancer samples using ChIP-seq data", submitted). The human bladder cancer cell line CL1207 was derived from a muscle-invasive bladder cancer (De Boer et al., 1997). 5x105 cells were immunoprecipitated per ChIP assay with 4 M-NM-<g of rabbit polyclonal antibodies against trimethyl histone H3 lysine 27 (Upstate Biotechnology, Santa Cruz, CA) and DynabeadsM-BM-. Protein A (Invitrogen, Cergy Pontoise, France) in dilution buffer containing 1% Triton X-100, 150 mM NaCl, 2 mM EDTA, 20 mM TrisM-bM-^@M-^SHCl at pH 8.0, and protease inhibitors. Six ChIP assays in the same experimental conditions were necessary to perform one ChIP-Seq experiment, so the total of 3x106 cells for each of the duplicates.

2014-01-07 | E-GEOD-44438 | biostudies-arrayexpress

Project description:RNA sequencing data of bladder cancer 5637 cell line

| PRJNA1184403 | ENA

Human bladder cancer cell line mRNA-seq

Project description:Human bladder cancer cell line mRNA-seq

| PRJNA564038 | ENA

The Androgen Receptor Directly Regulates CD44 Expression in Androgen Sensitive Bladder Cancer [ChIP-seq]

Project description:To study androgen receptor transcriptomic activation in the presence of androgen in bladder cancer cell lines. A uniquely derived AR expressing clone of the bladder cancer cell line UMUC3 was derived and validated prior to ChIP-seq experiments. Androgen receptor chromatin immunoprecipitation (AR ChIP-seq) was used to determine the overall expression changes in repsonse to treatment with synthetic androgen. Evaluation of genes associated with androgen receptor stimulation were used for focused analysis when combined with microarray data.

2021-03-21 | GSE147939 | GEO

H3K27me3 in human bladder transitional cell carcinoma cell line CL1207

2014-01-07 | GSE44438 | GEO

Gene expression profileing of DDR1 overexpression and control T24 human bladder cancer cell line

Project description:We performed RNA-seq analysis on xenograft mouse model generated by T24 human bladder cancer cell line with enforced expression of DDR1 or controls.

2022-10-19 | GSE191097 | GEO

Normal keratinocyte cell line and skin cancer cell line RNA-seq data

Project description:Normal keratinocyte cell line and skin cancer cell line RNA-seq data

| PRJNA989633 | ENA

The Androgen Receptor Directly Regulates CD44 Expression in Androgen Sensitive Bladder Cancer [gene expression]

Project description:To study androgen receptor transcriptomic activation in the presence of androgen in bladder cancer cell lines. A uniquely derived AR expressing clone of the bladder cancer cell line UMUC3 was derived and validated prior to microarray experiments. Microarrays were used to determine the overall expression changes in repsonse to treatment with synthetic androgen. Evaluation of genes associated with androgen receptor stimulation were used for focused analysis when combined with ChIP-seq data.

2021-03-21 | GSE147938 | GEO

Influence of low-input RNA from FF and FFPE samples on gene expression quantification by NanoString, microarray and RNA-seq: a comparative study [microarray]

Project description:Purpose: The goals of this study is to determine the best method of gene expression quantification (RNA-seq, Microarray, NanoString) and amplification kits adapted to low-input and/or low-quality RNA samples (FFPE samples) Methods: Mouse bladder cancer cell line (mouse bladder cancer cell line, BC57) and mouse normal mouse normal urothelium were fixed in formalin and embedded in paraffin (FFPE), andfesh frozen (FF) in liquid nitrogen. The total RNA of these 4 samples were tested in triplicate by 3 technologies (NanoString, RNA-seq and Microarray) and the results were compared to its reference (high-quality and high-input RNA of mouse bladder cancer cell line and mouse normal mouse normal urothelium). For microarray technology, each sample was tested by two amplification kits: GeneChip Pico WT and SensationPlus with 2 input quantities: 500pg and 2ng of total RNA, except for the SensationPlus which the recommended quantity is 50ng of total RNA. Microarray data, obtained with the kit GeneChip WT Plus from 100ng of total RNA from fresh frozen samples, was considered as the reference. All samples were hybridized on MTA 1.0 microarrays. Results obtained with the two tested kits were compared to those from GeneChip WT Plus. To determine which is the best kit suitable for microarray from low-input and low-quality RNA samples, we performed microarray control quality metrics, principal component analysis, and a differential analysis between the mouse bladder cancer cell lines and the mouse normal mouse normal urothelium for each input quantity, amplification kit and method of sample preservation (FF or FFPE). Results: According to our results, the GeneChip Pico kit are recommended for quantification of gene expression of FFPE and FF samples from 2ng of total RNA. This kit is not recommended for samples below 2ng of total RNA. The kit SensationPlus is recommended for FFPE samples at 50ng of total RNA.

2024-07-19 | GSE117675 | GEO

Homo sapiens

Project description:ATAC-seq data from 3 cancer cell lines and RNA-seq data from 1 cancer cell line

| PRJNA324504 | ENA